Sterin-Borda L, Gorelik G, Postan M, Gonzalez Cappa S, Borda E
Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Consejo Nacional de Investigaciones Científicas y Técnicas de la República Argentina (CONICET), Buenos Aires, Argentina.
Cardiovasc Res. 1999 Jan;41(1):116-25. doi: 10.1016/s0008-6363(98)00225-9.
Cardiac tissue from chagasic mice was studied to evaluate the expression and biological activity of beta-adrenoceptors in association with circulating beta-adrenoceptor-related autoantibodies.
BALB/c inbred mice that were either treated or not treated with atenolol (2.5 mg/kg) and infected or not infected with 1 x 10(4) trypomastigotes (CA-1 strain) were sacrificed weekly up to week nine. Morphological, binding and contractility studies were performed on the four different groups of animals. The effect of their serum antibodies was also assayed in binding and contractility studies on normal heart preparations.
Hearts from chagasic myocarditis mice showed a beta-adrenoceptor-related dysfunction, with a decrease in heart contractility, impaired response to exogenous beta-adrenoceptor agonist and a significant reduction in beta-adrenergic binding sites. Those effects were maximum at eight-nine weeks post-infection and were improved by treating infected mice with atenolol. In addition, serum or IgG from chagasic myocarditis mice was capable of interacting with cardiac beta-adrenoceptors, reducing the number of binding sites and inhibiting the contractile response to exogenous norepinephrine. IgG effects that were observed in normal myocardium, were highest in sera from mice eight-nine weeks post-infection and correlate with the degree of myocarditis. Moreover, chagasic autoantibodies from infected mice recognized a peptide corresponding to the sequence of the second extracellular loop of the human beta 1-adrenoceptor.
(1) The development of alterations in beta-adrenergic receptors, related to cardiac dysfunction, may be associated with the presence of circulating antibodies against these receptors and (2) it is possible that the chronic deposits of these autoantibodies in cardiac beta-adrenoceptors could lead to a progressive blockade with sympathetic denervation, a phenomenon that has been described in the course of chagasic myocarditis.
研究恰加斯病小鼠的心脏组织,以评估β-肾上腺素能受体的表达和生物活性,并探讨其与循环β-肾上腺素能受体相关自身抗体的关系。
将BALB/c近交系小鼠分为四组,分别为:未用阿替洛尔(2.5mg/kg)处理且未感染1×10⁴锥鞭毛体(CA-1株)的小鼠;用阿替洛尔处理且未感染的小鼠;未用阿替洛尔处理且感染的小鼠;用阿替洛尔处理且感染的小鼠。每周处死一组小鼠,直至第九周。对四组动物进行形态学、结合和收缩性研究。同时,在正常心脏标本的结合和收缩性研究中检测其血清抗体的作用。
恰加斯病心肌炎小鼠的心脏表现出与β-肾上腺素能受体相关的功能障碍,心脏收缩性降低,对外源性β-肾上腺素能激动剂的反应受损,β-肾上腺素能结合位点显著减少。这些效应在感染后八至九周最为明显,用阿替洛尔治疗感染小鼠可改善这些效应。此外,恰加斯病心肌炎小鼠的血清或IgG能够与心脏β-肾上腺素能受体相互作用,减少结合位点数量,并抑制对外源性去甲肾上腺素的收缩反应。在正常心肌中观察到的IgG效应,在感染后八至九周小鼠的血清中最高,且与心肌炎程度相关。此外,感染小鼠的恰加斯病自身抗体识别一种与人β1-肾上腺素能受体第二个细胞外环序列相对应的肽。
(1)与心脏功能障碍相关的β-肾上腺素能受体改变的发生,可能与循环中针对这些受体的抗体的存在有关;(2)这些自身抗体在心脏β-肾上腺素能受体中的慢性沉积可能导致交感神经去神经支配的进行性阻滞,这一现象在恰加斯病心肌炎过程中已有描述。